Remove generics
article thumbnail

FDA Approves Generic OTC Naloxone Nasal Spray

Drug Topics

Amneal Pharmaceuticals said its generic naloxone hydrochloride nasal spray is now available in the US following FDA approval.

FDA 123
article thumbnail

California to sell state-branded Narcan generic to cut costs

pharmaphorum

California will start selling its own generic of overdose reversal agent naloxone in another example of the use of government-level purchasing power to reduce drug prices

111
111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Latuda generic availability, cost, and dosage

The Checkup by Singlecare

Although many individuals refer to Latuda as a brand-name medication, a generic version is available. The generic name is lurasidone, and it can be found at pharmacies across the United States. Continue reading to learn more about Latuda and its generic, lurasidone. Lurasidone vs. Latuda: Is there a difference?

Dosage 93
article thumbnail

Opinion: Shortages of generic drugs can’t be blamed solely on group purchasing organizations

STAT

The Hatch-Waxman Act of 1984, which gave rise to the modern generic drug market, was one of the most significant cost-reducing policy innovations of the last 40 years. In 2021 alone, the use of generic and biosimilar drugs saved $373 billion in health expenditures. Today, however, generic drugs seem to be a victim of their success.

article thumbnail

Astellas’ generic Myrbetriq defence knocked back again

pharmaphorum

Generics of Astellas’ Myrbetriq for urinary incontinence are looming in the US after a court recommended against an injunction on copycats from Zydus and Lupin

95
article thumbnail

Vyvanse generic availability, cost, and dosage

The Checkup by Singlecare

Your guide to adult ADHD treatment Is there a generic for Vyvanse? The FDA approved the generic version of Vyvanse ( lisdexamfetamine ) on August 28, 2023, and began to hit the shelves shortly after that in all previously available Vyvanse strengths. RELATED: What are authorized generics? RELATED: Considering an ADHD medication?

Dosage 52
article thumbnail

Generics propelling pharmaceutical parenteral packaging market

European Pharmaceutical Review

Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. Overall, increasing demand for generic medicines will be a significant factor for growth. This is aligned with a CAGR of 4.47 percent between 2024 and 2031. Catalent Inc.